712 related articles for article (PubMed ID: 25034931)
41. Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0).
Deo SV; Bhutani M; Shukla NK; Raina V; Rath GK; Purkayasth J
J Surg Oncol; 2003 Dec; 84(4):192-7. PubMed ID: 14756429
[TBL] [Abstract][Full Text] [Related]
42. [Clinical evaluation of effects from neoadjuvant chemotherapy with epirubicin plus paclitaxel in cases of locally advanced breast cancer--comparative study of treatment with 2 and 4 cycles].
Tong F; Yang D; Zhou B; Cao Y; Liu P; Liu H; Wang S; Qiao X; Zhang J
Gan To Kagaku Ryoho; 2004 Feb; 31(2):205-8. PubMed ID: 14997752
[TBL] [Abstract][Full Text] [Related]
43. Neoadjuvant chemotherapy for locally advanced breast cancer.
Specht J; Gralow JR
Semin Radiat Oncol; 2009 Oct; 19(4):222-8. PubMed ID: 19732686
[TBL] [Abstract][Full Text] [Related]
44. Breast conservation and sentinel lymph node biopsy after neoadjuvant systemic therapy.
Veronesi P; Gentilini O; Fernandez JR; Magnoni F
Breast; 2009 Oct; 18 Suppl 3():S90-2. PubMed ID: 19914551
[No Abstract] [Full Text] [Related]
45. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
[TBL] [Abstract][Full Text] [Related]
46. Lessons from the neoadjuvant setting on how best to choose adjuvant therapies.
von Minckwitz G; Loibl S; Maisch A; Untch M
Breast; 2011 Oct; 20 Suppl 3():S142-5. PubMed ID: 22015282
[TBL] [Abstract][Full Text] [Related]
47. [Does primary chemotherapy really increase the rate of breast conserving treatments?].
Hennequin C; Espié M; Misset JL; Maylin C
Cancer Radiother; 2004 Feb; 8(1):48-53. PubMed ID: 15093201
[TBL] [Abstract][Full Text] [Related]
48. Breast conservative surgery for operable invasive ductal carcinoma after neoadjuvant chemotherapy or hormonal therapy- a challenge for breast surgeon: a review based on literature and experience.
Bobin JY; Al-Khaledi K; Ahmad J
Gulf J Oncolog; 2011 Jan; (9):45-51. PubMed ID: 21177208
[TBL] [Abstract][Full Text] [Related]
49. Optimizing the indication for breast-conservative surgery (BCS) in patients with locally-advanced breast cancer.
Mazilu L; Suceveanu AI; Tomescu D; Ciufu N; Baz R; Suceveanu AP; Parepa IR; Tofolean DE; Voinea F
Chirurgia (Bucur); 2013; 108(4):478-81. PubMed ID: 23958089
[TBL] [Abstract][Full Text] [Related]
50. Locally advanced breast cancer and postmastectomy radiotherapy.
Recht A
Surg Oncol Clin N Am; 2000 Jul; 9(3):603-20, x-xi. PubMed ID: 10853145
[TBL] [Abstract][Full Text] [Related]
51. Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy.
Balduzzi A; Leonardi MC; Cardillo A; Orecchia R; Dellapasqua S; Iorfida M; Goldhirsch A; Colleoni M
Cancer Treat Rev; 2010 Oct; 36(6):443-50. PubMed ID: 20304562
[TBL] [Abstract][Full Text] [Related]
52. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
53. [Neoadjuvant Chemotherapy in breast cancer].
Suzuki E; Toi M
Nihon Rinsho; 2006 Mar; 64(3):536-9. PubMed ID: 16529046
[TBL] [Abstract][Full Text] [Related]
54. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
55. Radiotherapy Issues After Neoadjuvant Chemotherapy.
Mak KS; Harris JR
J Natl Cancer Inst Monogr; 2015 May; 2015(51):87-9. PubMed ID: 26063895
[TBL] [Abstract][Full Text] [Related]
56. Neoadjuvant chemotherapy for operable breast cancer: is this the future?
Mamounas EP
Clin Breast Cancer; 2003 Apr; 4 Suppl 1():S10-9. PubMed ID: 12756074
[TBL] [Abstract][Full Text] [Related]
57. What's new in neoadjuvant therapy for breast cancer?
Beasley GM; Olson JA
Adv Surg; 2010; 44():199-228. PubMed ID: 20919523
[TBL] [Abstract][Full Text] [Related]
58. Neoadjuvant therapy for breast cancer.
Zardavas D; Piccart M
Annu Rev Med; 2015; 66():31-48. PubMed ID: 25386936
[TBL] [Abstract][Full Text] [Related]
59. International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).
Amoroso V; Generali D; Buchholz T; Cristofanilli M; Pedersini R; Curigliano G; Daidone MG; Di Cosimo S; Dowsett M; Fox S; Harris AL; Makris A; Vassalli L; Ravelli A; Cappelletti MR; Hatzis C; Hudis CA; Pedrazzoli P; Sapino A; Semiglazov V; Von Minckwitz G; Simoncini EL; Jacobs MA; Barry P; Kühn T; Darby S; Hermelink K; Symmans F; Gennari A; Schiavon G; Dogliotti L; Berruti A; Bottini A
J Natl Cancer Inst Monogr; 2015 May; 2015(51):90-6. PubMed ID: 26063896
[TBL] [Abstract][Full Text] [Related]
60. Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy.
King TA; Morrow M
Nat Rev Clin Oncol; 2015 Jun; 12(6):335-43. PubMed ID: 25850554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
